These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 31163475)
21. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
22. [Colorectal cancer in inflammatory bowel disease]. Henriksen M; Moum B Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483 [TBL] [Abstract][Full Text] [Related]
24. [Colorectal cancer in ulcerative colitis]. Laugesen KB; Tøttrup A Ugeskr Laeger; 2014 Jan; 176(4A):V07130441. PubMed ID: 25347248 [TBL] [Abstract][Full Text] [Related]
25. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis. Lee DU; Menegas S; Lee KJ; Pu A; Bhowmick K; Ponder R; Fan GH; Chou H; Lee K; Urrunaga NH Dig Dis Sci; 2023 Sep; 68(9):3781-3800. PubMed ID: 37450231 [TBL] [Abstract][Full Text] [Related]
26. The epidemiology of inflammatory bowel disease. Burisch J; Munkholm P Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629 [TBL] [Abstract][Full Text] [Related]
27. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly. Sturm A; Maaser C; Mendall M; Karagiannis D; Karatzas P; Ipenburg N; Sebastian S; Rizzello F; Limdi J; Katsanos K; Schmidt C; Jeuring S; Colombo F; Gionchetti P J Crohns Colitis; 2017 Mar; 11(3):263-273. PubMed ID: 27797918 [TBL] [Abstract][Full Text] [Related]
28. Anti-TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease. Nedelkopoulou N; Vadamalayan B; Vergani D; Mieli-Vergani G J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):100-105. PubMed ID: 28953529 [TBL] [Abstract][Full Text] [Related]
29. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Stephens J; Goldstein R; Crippin J; Husberg B; Holman M; Gonwa TA; Klintmalm G Transplant Proc; 1993 Feb; 25(1 Pt 2):1122-3. PubMed ID: 7680144 [No Abstract] [Full Text] [Related]
30. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM; Rybicki LA; Lashner BA Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486 [TBL] [Abstract][Full Text] [Related]
31. Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease. Tse CS; Loftus EV; Raffals LE; Gossard AA; Lightner AL Aliment Pharmacol Ther; 2018 Jul; 48(2):190-195. PubMed ID: 29808485 [TBL] [Abstract][Full Text] [Related]
37. Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Parian A; Lazarev M Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672 [TBL] [Abstract][Full Text] [Related]
38. Colorectal Neoplasia and Inflammatory Bowel Disease. Cannon J Surg Clin North Am; 2015 Dec; 95(6):1261-9, vii. PubMed ID: 26596926 [TBL] [Abstract][Full Text] [Related]